NL-OMON45166已完成3 期
A randomized phase III study of monotherapy docetaxel or intercalated erlotinib docetaxel combination therapy in patients with relapsed EGFR wild type, ALK negative non squamous cell carcinoma. (NVALT 18 study)<br> - NVALT 18
Stichting NVALT studies0 个研究点目标入组 230 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 230
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •1. Histologically or cytologically confirmed EGFR wild type, ALK negative, non squamous cell carcinoma, locally advanced and metastatic disease stage IIIB and IV. Evidence of disease progression after one cytotoxic treatment platinum containing regimen or immunotherapy.
- •2. ECOG PS 0-1.
- •3. Age > 18 years.
排除标准
- •1. Patients with medical risks because of non-malignant disease as well as those with active uncontrolled infection.
- •2. Concomitant treatment with any other experimental drug under investigation.
研究者
相似试验
已完成
不适用
A retrospective observational study of monotherapy outcomes on the efficacy of third-line or later treatment for patients with HER2 positive unresectable recurrent or metastatic gastric cancer previously treated with trastuzumabHER2 positive unresectable recurrent or metastatic gastric cancerJPRN-UMIN000040853Graduate school of Medicine OSAKA UniversityDepartment of Gastroenterological Surgery100
已完成
不适用
Dapagliflozin Efficacy & Safety as Mono or Combination therapy in reduction of HbA1C and Body Weight in Type II Diabetes Mellitus Patients.Type 2 Diabetes Mellitus.Type 2 Diabetes mellitusIRCT20170614034526N5Hilton Pharma Pvt Ltd400
进行中（未招募）
不适用
Prospective study of switch to 3TC monotherapy with evaluation of replication capacity in patients with virologic failure and 3TC resistance (a multicenter prospective clinical study within the SHCS) SHCS-Projekt Nr. 408 - 3TC Mono StudyHIV patients with virological treatment failure due to multi-drug-resistant virus including 3TC resistanceEUCTR2004-002633-39-DEProf. Dr. med. Milos Opravil, Universitätsspital Zürich30
进行中（未招募）
1 期
A study in patients with Myelodysplastic SyndromesMyelodysplastic SyndromesMedDRA version: 14.1Level: HLTClassification code 10028536Term: Myelodysplastic syndromesSystem Organ Class: 100000004851EUCTR2013-003235-30-ESilly S.A.140
进行中（未招募）
1 期
A study in patients with Myelodysplastic SyndromesMyelodysplastic SyndromesMedDRA version: 14.1Level: HLTClassification code 10028536Term: Myelodysplastic syndromesSystem Organ Class: 100000004851EUCTR2013-003235-30-ITEli Lilly and Company43